MARCH 6-7, 2013 | WASHINGTON, DC | Sheraton Crystal City Hotel

 

 

NOTE: The 4TH ANNUAL TRAUMATIC BRAIN INJURY CONFERENCE is coming back to Washington, DC in March 2014. Please join our mailing list or request a brochure for next year's event HERE.


Organized by



SPONSOR

          

calendar-link-130x104





Twitter

Join the TBI R&D Network

Media Partners

Informa Healthcare publishes over 160 journals, which include Developmental Neurorehabilitation, Brain Injury, International Journal of Neuroscience and much more.


 

About this Conference

ARROWHEAD'S 3rd Annual Traumatic Brain Injury Conference is bringing researchers, clinicians in industry, academia and the military, and regulators together to discuss how best to achieve the goal of bringing new therapies to market for TBI. In order to do so, there is a strong need for consensus regarding the following key subject areas, which will be covered in depth via plenary sessions and panel sessions at this year's conference:

CLASSIFICATION
  • Pathophysiology and molecular-based classification
  • To determine efficacy and clinical endpoints for trials
DIAGNOSTICS
  • Identifying and measuring pathophysiological processes
  • To determine which cases will need what types of post-acute care/therapy
IMAGING
  • Utilization in patient selection and outcome assessment in clinical trials
  • Its role in pathophysiology-based classification
OUTCOMES RESEARCH
  • Coalesce to help guide future clinical trials and assessment of therapy
  • CTE research
  • Neuropsychiatric outcomes
Speakers from academia, industry, the military and government will be addressing traumatic brain injury from a variety of perspectives in order to provide attendees with a holistic perspective on the diagnosis, treatment and outcomes associated with traumatic brain injury. To this end, presenters will be addressing the following issues:
  • Advances in neuroimaging for TBI
  • Clinical trial design for new TBI therapeutics
  • Implementation of biomarkers for stratification, outcome prediction and therapeutics intervention monitoring
  • Pre-clinical modeling and translating results to the clinic
  • Drug delivery (blood-brain barrier) challenges facing development of new therapies
  • Treatment of acute as well as post-acute/chronic neurorehabilitation
  • Halting secondary injury in TBI
  • Cell therapy potential for TBI
  • Cognitive measures of TBI and outcomes
  • Neuroprotection as a therapeutic intervention
  • Regulatory perspectives on clinical trials and companion diagnostic development and commercialization
 

Key Questions Addressed

  • How can animal model results translate to clinical research?
  • What are the key patient populations for future clinical trials?
  • What outcomes should new clinical trials measure?
  • How can the blood-brain barrier be overcome in drug delivery?
  • How can companion diagnostics and biomarkers improve therapeutic interventions and outcome prediction?
  • What are the regulatory barriers facing developers of both companion diagnostics and new therapies?
 

Exhibitors

  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator

Last Year's Conference

  

View the Agenda

 

Who Should Attend

Brain Injury Research Associates
Business Development Execs & Associates
Chief Executive Officers
Chief Operating Officers
Chief Medical Officers
Chief Scientific Officers
Clinical Pharmacology Fellows
Clinical Researchers
Consultants
Directors
Group Leaders
Managers
Neuropsychologists
Neuroscientists
Medical Directors
Post-doctoral Fellows
Presidents
Principal Investigators
Principal Scientists
Professors
Program Managers
Research & Development Execs & Associates
Research Associates
Research Fellows
Research Scientists
Scientists
Senior Scientists
Students
Team Leader
Vice Presidents
VPs, Directors, Managers of Product Development

Share with Colleagues

top